562 Real-world assessment of current treatment patterns and clinical outcomes among patients with EGFR and ALK wild type non-small cell lung cancer (NSCLC) in the US

• Lyudmila Bazhenova,
• Jonathan Kish,
• Bruce Feinberg,
• Beilei Cai,
• Nydia Caro

Affiliations

Lyudmila Bazhenova

Aff4 grid.266100.30000000121074242University of California San Diego CA USA

Jonathan Kish

1Cardinal Health, Dublin, OH, USA

Bruce Feinberg

1Cardinal Health, Dublin, OH, USA

Beilei Cai

3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

Nydia Caro

3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA